title: Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women.
abstract: The intake of (n-3) long-chain PUFA is associated with a decreased risk of fatal myocardial infarction. Whether this effect is attributable to the effects of docosahexaenoic acid [22:6(n-3) (DHA)] on vascular function, particularly at intakes <1 g/d, is unknown. We report a randomized, double-blind, crossover, placebo controlled trial of 0.7 g DHA/d as a purified algal derived triacylglycerol (1.5 g/d) vs. placebo (1.5 g olive oil/d) on vascular function and biochemical indices of endothelial dysfunction in 38 healthy men and women, aged 40-65 y. Each treatment phase lasted 3 mo, separated by a 4 mo washout period. Supplementation increased the proportion of DHA in erythrocytes lipids by 58%, compared with placebo. Arterial compliance and endothelium independent and dependent responses, plasma concentrations of C-reactive protein, soluble thrombomodulin, E-selectin, von Willebrand factor antigen, and urinary microalbumin and isoprostane excretion were unaffected by treatment. Diastolic blood pressure decreased by 3.3 mm Hg (95% CI -6.1 to -0.6; P = 0.01). Heart rate tended to be 2.1 beats/min lower after DHA treatment than after the placebo period (P = 0.15). The results indicate that a moderate increase in the daily intake of DHA to approximately 0.7 g DHA lowers diastolic BP but does not influence indices of endothelial function or arterial stiffness in the short term.
authors: Nutritional Sciences Research Division, King's College London SE1 9NH, UK.
authors: Hannah E
authors: HE
authors: Theobald
authors: Alison H
authors: AH
authors: Goodall
authors: Naveed
authors: N
authors: Sattar
authors: Duncan C S
authors: DC
authors: Talbot
authors: Philip J
authors: PJ
authors: Chowienczyk
authors: Thomas A B
authors: TA
authors: Sanders
mesh_terms: D001794:Blood Pressure / Q000187:drug effects*; D018592:Cross-Over Studies; D004281:Docosahexaenoic Acids / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D004281:Docosahexaenoic Acids